We have previously demonstrated that blocking Siglec-1 receptor on MDM resulted in 90–95% inhibition of HIV-1 infection, whereas blocking CD4 receptor inhibited infection in 50–55% of MDM (21). The gene discussed is CD4; the disease is HIV-1 infection.